TRANSLATIONAL DEVELOPMENT AC

TDACNASDAQ

🏆 #3246 by market capUS Equity

$10.86▼ $0.00 (−0.01%)

Live

1h—

24h▼ 0.0%

7d▲ 0.1%

14d▲ 0.2%

30d▲ 1.5%

1y▲ 5.3%

🏦Market Cap

$267M

Small Cap

📈Revenue Growth (YoY)

-100.0%

Declining

📊Gross Margin

0.0%

Thin

💵FCF Margin

0.0%

Thin

⚖️P/S Ratio

0.0x

Cheap

Otter Score

Fair

Trading Snapshot

Day Range: $10.78 – $10.95
52-Week Range: $10.32 – $10.95
Volume: $3.03B
Avg Volume: $2.58B
Shares Outstanding: 24.6M
Next Earnings: Sep 5, 2026

Fundamentals Snapshot

Annual Revenue: $17M
Last Q Revenue: $5M
P/E Ratio: 37.7
P/S Ratio: 0.0x
EPS (TTM): $0.36
Dividend Yield: 0.00%

Why Investors Own TDAC

✓High-growth profile — revenue up +27.4% YoY with expanding US Equity exposure.
✓Healthy economics — 45% gross margin and 16% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$17M▲ +28.7% YoY

Gross Margin (TTM)

44.9%▲ +2.8% YoY

Operating Income (TTM)

$6M▲ +28.7% YoY

Free Cash Flow (TTM)

$3M▲ +28.7% YoY

About TRANSLATIONAL DEVELOPMENT AC

Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.

🦦